Stock Events

Stock Events

Lineage Cell Therapeutics (BT3.F) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.04

-0.03

-0.03

-0.02

Details

Expected EPS

-0.022978801820000002

Actual EPS

-0.017872600000000002

Surprise EPS

0.01

Surprise Percent

+22.22%

Description

Lineage Cell Therapeutics (BT3.F) has reported earnings of -0.017872600000000002 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.